Chemours Reports Mixed Q1 2026: TSS Shines, APM Struggles Amid Debt Reduction
Event summary
- Chemours reported Q1 2026 net sales of $1.4B, up 1% YoY, with TSS segment achieving record sales and 12% YoY growth in Opteon™ Refrigerants.
- Net loss attributable to Chemours widened to $29M (vs. $5M loss in Q1 2025) due to higher financing costs and SG&A expenses.
- Received $287M from Kuan Yin site sale, enabling €140M debt repayment in April 2026.
- APM segment suffered a 17% YoY sales decline due to Washington Works plant outage and SPS Capstone™ line closure.
- Full-year 2026 outlook: 3-5% net sales growth, $800M-$900M Adjusted EBITDA, and net leverage ratio below 3.8x.
The big picture
Chemours' Q1 2026 results highlight the stark contrast between its high-performing TSS segment and the struggling APM division. The company's strategic focus on debt reduction through asset sales is critical amid uncertain economic conditions. The chemicals industry continues to face volatility in raw material costs and regulatory pressures, making operational agility and cost discipline key differentiators.
What we're watching
- Segment Recovery
- Whether APM can rebound in Q2 2026 following the Washington Works plant outage resolution.
- Debt Reduction Pace
- The pace at which Chemours can reduce its net leverage ratio below 3.8x by year-end 2026.
- TSS Growth Sustainability
- How long Chemours can maintain double-digit growth in Opteon™ Refrigerants amid competitive pressures.
Related topics